Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
Effective July 1, 2026, Mobility Global appointed a substantially reconstituted board of seven new directors (Eric W. Aboaf, William W. Eager, Heather Lavallee, Monique F. Leroux, Mark S. Peek, Shilpa Ranganathan, and Alexander Taussig), appointed Joseph R. Hinrichs as Chair, and appointed three new officers: Scott Fredericks as President of CARFAX, Joseph S. LaFeir as President of Mobility Business Solutions, and Renato Negro as Chief Accounting Officer. These appointments reflect the company's transition to independent public company status following its separation from S&P Global.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The filing discloses both a director departure (Alexandra Herger's resignation effective July 1, 2026) and a director appointment (John Maxwell appointed to succeed her on the same date). While both events occur, the principal disclosed action centers on the appointment of Maxwell as a director and member of the Nominating and Governance Committee, with nomination for a full 3-year term. The appointment is the forward-looking governance action that materially affects board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Robert R. Franklin, Jr. was appointed as a director and Vice Chairman of Prosperity and Prosperity Bank effective upon completion of the Stellar merger on July 1, 2026, with a three-year employment agreement providing $1.12M base salary, 175% bonus target, $3M signing bonus, 25,000 RSA award, and severance protections.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 7.01
The filing discloses the appointment of Thomas Addis as Chief Revenue Officer of Sprinklr, effective July 1, 2026, reporting to the CEO. This is a material executive appointment at the C-suite level. The press release emphasizes his extensive go-to-market and revenue leadership experience across high-growth enterprise technology companies, indicating this is a significant leadership change intended to drive growth and execution.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-01
The 6-K discloses the appointment of Brandon Craig as Chief Executive Officer and Executive Director of BHP Group Limited, effective 1 July 2026. The filing furnishes an Initial Director's Interest Notice detailing Craig's shareholdings and equity interests upon taking office. This is a material executive appointment at the C-suite level of a major multinational mining company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Alfred F. Kelly, Jr. to Prologis' board of directors on June 29, 2026. Kelly is a prominent executive with significant leadership experience (former CEO of Visa, president of American Express) and currently serves on the board of General Motors. The appointment of a director with this caliber of experience and external board responsibilities is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
ExxonMobil completed a comprehensive leadership transition effective at the Effective Time of the redomiciliation merger, with 12 directors resigning and 3 new directors (Neil A. Chapman, Neil A. Hansen, Jack P. Williams, Jr.) being elected, plus appointment of new named executive officers including James R. Chapman as President and Treasurer and Susan E. Buchanan as Vice President and Controller.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
John R. Linker was appointed as Executive Vice President of Finance and Chief Financial Officer effective July 1, 2026, succeeding Gregory P. Rustowicz. The appointment includes a base salary of $600,000, a 70% target bonus, and 165% long-term equity incentive participation. Thomas Oddo was also promoted to Chief Accounting Officer with an associated equity increase.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
The filing discloses both a director resignation (Andrew Levin) and the election of a new director (Breanna O'Reilly, Ph.D.) on the same date. While both events are present, the principal action emphasized in the disclosure is Dr. O'Reilly's election to the Board effective immediately, with detailed information about her compensation package (70,284 option grant at $13.36/share, $40,000 annual cash retainer, and future equity grants). The appointment is the forward-looking event and receives substantially more disclosure than the departure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Ravi Thanawala was appointed as Executive Vice President and Chief Financial Officer effective August 3, 2026, with a compensation package including $1M base salary, $2.5M in target equity grants, and a $1M sign-on bonus. Michael Mathias transitioned to a non-officer Strategic Advisor role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Maurice Tulloch was appointed to the Board of Directors of Reinsurance Group of America, effective July 1, 2026. Tulloch is the former CEO of Aviva Group and brings extensive executive and operational expertise to strengthen the Board's oversight and global perspective.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-01
The 6-K discloses the appointment of Mr. Gang Liu as Chief Financial Officer of Chanson International Holding, effective immediately on June 26, 2026. While the report also mentions Ms. Jihong Cai's resignation as CFO on the same date, the principal disclosed action is the appointment of a named executive to a C-suite officer role. The filing includes Mr. Liu's extensive 30+ years of accounting and financial management experience and references employment and indemnification agreements, consistent with a material executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Inogen appointed Andrew Reding as Executive Vice President and Chief Operating Officer, a newly created C-suite role effective July 6, 2026. The appointment includes compensatory arrangements comprising a base salary of $500,000, a 70% bonus target, a $100,000 sign-on bonus, and 130,000 RSUs vesting over three years, approved under Nasdaq Listing Rule 5635(c)(4).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Stephanie C. Bush was elected to the Board of Directors of Employers Holdings, Inc. on June 25, 2026, with her term commencing July 1, 2026, increasing board size to nine members. Her appointment reflects her extensive insurance leadership background and expertise in underwriting, product, and distribution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
The filing discloses the election of two new directors (Diya Jolly and Michael Yang) to the Board effective June 29, 2026, along with significant governance changes including the appointment of Shane Trigg as Chairman and Winifred Webb as Lead Independent Director. While the section also includes the retirement of two long-serving directors (Andreas von Blottnitz and Janet Kerr), the primary focus and substantive action centers on the appointment of new directors and restructuring of board leadership roles, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the election of George M. Ristau, Jr. to the Board of Directors on July 1, 2026, filling a vacancy created by the passing of James A. Lentz, and his concurrent appointment to the Audit Committee. While the section mentions the departure context (death of Lentz), the principal disclosed action is the appointment of a new director and committee member, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02 discloses the appointment of Joshua Girnun to Nova Minerals' Board of Directors as a Class I director, effective July 1, 2026. The Board expanded from five to six directors to accommodate this appointment. The press release emphasizes Girnun's significant institutional finance and technical resource background from JP Morgan, positioning him as a key addition during the company's transition to production. This is a material governance event affecting board composition and strategic oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
The filing discloses the appointment of Chris Janis as a member of the Board of Directors, Chairperson of the Audit Committee, and member of the Compensation Committee on July 1, 2026. Item 5.02 explicitly covers this appointment, and the press release emphasizes his 35+ years of financial and governance expertise from PwC and prior CFO roles. This is a material governance event affecting board composition and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
X4 Pharmaceuticals appointed Kelly Gold as a Class II director effective July 1, 2026, increasing the board size from five to six directors. Ms. Gold, an experienced CFO with prior roles at Biogen and Deutsche Bank, was also appointed to the Audit Committee as an independent director.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The Board of Directors appointed Ali Keshavarz as a director effective June 26, 2026, expanding the Board from eleven to twelve members. This is a clear executive appointment of a named individual to a director position. While the disclosure also mentions standard director compensation, the principal disclosed action is the appointment itself, not a compensatory arrangement. Keshavarz's background in AI and advanced analytics at CVS Health is highlighted as strategically relevant to the company's growth strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Terra Grantham was appointed as Chief Financial Officer of CPI Card Group Inc. effective June 29, 2026, after serving as Interim CFO since February 2026. The appointment includes compensatory arrangements comprising a base salary of $450,000, short-term and long-term incentive targets, and a $300,000 RSU grant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the Board's approval of Dr. Wah Shing Lam's appointment as an Executive Director of ModuLink Inc., effective July 1, 2026. Dr. Lam, currently serving as Chief Technology Officer, is being elevated to the Board. This is a clear executive appointment event where the principal disclosed action is a person taking on a new role (Board membership), even though he retains his existing CTO position. The appointment is material as it affects the composition of the Company's leadership and Board governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Dynatrace appointed two new directors to its Board of Directors, effective June 30, 2026: George Riedel (Class I) and Dan Streetman (Class II). The appointments follow constructive engagement with activist investor Starboard Value LP and represent a material governance change, with both appointees bringing significant technology and operational expertise relevant to the company's strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
Kenneth M. Hartwick, former CEO and CFO of Ontario Power Generation, was elected to PPL Corporation's Board of Directors effective July 1, 2026, and assigned to the People and Compensation Committee and Finance Committee.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-30
Item 5.02
The filing discloses both the retirement of Patrick Farrell as CFO and the resignation of Dana Staggs as President, but centers on the appointment of Katherine Jones as Chief Financial Officer effective June 30, 2026. While two departures occur, the principal affirmative action disclosed is Jones's appointment to a key executive role, supported by the press release emphasizing her qualifications and the Board's confidence in her capabilities. The appointment of a new CFO is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-30
The Board approved the re-appointment of Ms. Vibha Paul Rishi as an Independent Director for a second term commencing January 23, 2027 through December 31, 2028, subject to shareholder approval. Although technically a re-appointment rather than an initial appointment, this constitutes an executive appointment under Item 5.02 as it is the principal action disclosed—a director taking a role for a new term. The disclosure includes her qualifications, board experience, and independence confirmation as required by SEBI Listing Regulations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The Board appointed Matthew Pauls as a Class I director on June 29, 2026, increasing the Board size from seven to eight members. While the disclosure includes compensatory details (stock option grant of 6,000 shares), the principal disclosed action is the appointment of a new director with substantial industry experience in biopharmaceuticals. This is a governance event centered on a person taking a role, making exec_appointment the most salient classification.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
EX-99.1
The exhibit announces the completion of a planned CEO transition with two key executive appointments effective July 1, 2026: Ender Özgün as Chief Executive Officer of Hepsiburada with overall company responsibility, and Hakan Karadoğan as CEO of the Delivery business. While Nilhan Gökçetekin's departure is also disclosed, the principal disclosed action is the appointment of new leadership to critical executive roles, making this an exec_appointment event. This is material as it represents a significant change in the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Charlie Cole as Chief Executive Officer and Board member effective July 13, 2026, which is the principal action. While Andrew McLean's departure as CEO and Board member is also disclosed, the salient event centers on the new CEO appointment with detailed compensation terms ($1.1M base, $550K signing bonus, $2.5M in equity grants, and $3.025M+ annual LTI). This is a material executive leadership change for the registrant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Margaret M. Weichert to the Board of Directors of Primis Financial Corp. and Primis Bank, effective June 25, 2026, at the recommendation of the Corporate Governance Committee. The prose centers on her election and appointment to the boards and the Corporate Governance Committee, with detailed background on her qualifications. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-30
EX-99.1
The announcement discloses the Board's appointment of Søren Steenberg Jensen, EVP Head of Asset Management, as the successor to CEO Mikael Skov, effective 1 September 2026. While the disclosure also mentions Skov's departure, the principal disclosed action is the appointment of a new CEO to lead the company. This is a material executive succession at the top of the organization affecting investor assessment of leadership continuity and strategy execution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Joseph Manhede as Principal Accounting Officer effective July 8, 2026, following the resignation of John Militello. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a named executive to a principal officer role (Principal Accounting Officer), making exec_appointment the most salient classification. The appointment of a Principal Accounting Officer is material to investors as it affects financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-30
Item 5.02
The Company appointed three new directors—Yongchen Lu, Monica Roma Wilson, and Eduardo Agustin Ojea Quintana—effective June 24, 2026, expanding the board from two to five members and establishing the governance structure of the newly public SPAC.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-06-30
The 6-K discloses the appointment of two new independent directors (Ms. Tian Ke and Mr. Lin Junteng) effective June 30, 2026, along with the simultaneous resignation of two existing directors (CHAN KA MAN and LAI HO YIN). While both departures and appointments occur, the principal disclosed action is the appointment of the new directors to fill those vacancies, making exec_appointment the primary classification. The reconstitution of board committees reflects the structural consequence of these director changes. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
Z Squared Inc. appointed Jeffery Harris as Chief Technology Officer, effective June 24, 2026. Harris, founder and CTO of Paradox Data LLC (which the Company is acquiring), brings expertise in AI infrastructure, data center design, and immersion cooling technology. The appointment includes compensatory arrangements of $225,000 base salary, $675,000 annual bonus RSUs, and a stock option grant.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
EX-99
The exhibit discloses the Board's approval of two executive appointments: Mr. Puneet Sharma as Chief Financial Officer-Designate (effective September 1, 2026, becoming CFO on December 1, 2026) and Mr. Jigar Shah as General Counsel-Designate (effective August 20, 2026, becoming General Counsel on October 1, 2026). Both will be Senior Management Personnel, and Sharma will become a Key Managerial Person under Indian law. These are material C-suite appointments at a major bank that would affect investor assessment of management quality and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
Chae Lee was appointed as Chief Executive Officer and director of Magnachip Semiconductor, effective July 1, 2026. Camillo Martino transitioned from Interim CEO to Chairman. The appointment represents a significant leadership change at the company level.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of two new directors (Go Jin Young and Han Eui Seok) to the Board, effective June 30, 2026, following an increase in board size from five to six directors. While Ham Jung Kyu's resignation is also mentioned, the principal disclosed action centers on the two director appointments and the formation of a Compensation Committee with Han Eui Seok as Chair. This is a material governance event affecting board composition and committee structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-30
Item 5.02
ALX Oncology appointed Scott Garland as Chairman of the Board (effective June 29, 2026) and Michael Listgarten as General Counsel (effective immediately), representing a significant governance transition. Corey Goodman, co-founder, stepped down as Chairman after more than a decade of leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Cynthia T. Jamison to Sunbelt Rentals' Board of Directors, effective August 1, 2026, along with her appointment to the Audit Committee. The principal disclosed action is a person taking a governance role. While the Board was expanded from eight to nine directors, the core event is the election and appointment of Ms. Jamison, a director with extensive board and executive leadership experience across major public companies (Darden, Advance Auto Parts, IFF) and financial expertise as a former CFO and CPA.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
The 6-K announces the appointment of four individuals—Mr. Xuan He, Ms. Xinyi Wei, Ms. Zhen Liao, and Ms. Yiwen Zhang—as executive directors of the Board, effective June 30, 2026. Mr. He also serves as chief financial officer. This is a material governance event involving the appointment of multiple senior officers to the board, expanding it from five to nine members with six executive directors and three independent directors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
The 6-K discloses the appointment of Chung Wai Wong as a director and member of three board committees (Nominating and Corporate Governance, Audit, and Compensation) effective June 30, 2026. The filing provides her biographical information, independence determination under Nasdaq rules, and compensation terms ($12,000 annually). This is a clear executive appointment to the board with material governance implications.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
Thomas D. Hennessy was appointed to the SPAC Board on June 25, 2026, pursuant to a Transfer Agreement, bringing extensive SPAC leadership and M&A expertise to the company's governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Karl Olsoni to the Board of Directors and the Audit Committee, effective June 30, 2026. While the disclosure also includes compensatory terms (annual cash retainer of $150,000 and annual stock award of $150,000), the principal action is the appointment itself. Board appointments are material to investors as they affect governance and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
The filing discloses the appointment of Allen C. Harper as Interim Chief Executive Officer and Principal Executive Officer of Rocky Mountain Chocolate Factory, effective immediately on June 30, 2026, for a 180-day term. This is a material executive appointment to the principal executive officer role, disclosed under Item 8.01 (Other Events) with supporting press release. The appointment of a new CEO is material to investors assessing the registrant's leadership and strategic direction.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-30
The 6-K discloses the appointment of Frank Zheng as Chief Executive Officer (effective June 30, 2026), Chang-Wei Chiu as Chairman and Compensation Committee Chair (effective June 30, 2026), and Tokihiko Shimizu as an independent director (effective June 30, 2026). While the filing also mentions the departures of Moore Xin Jin and Björn Schmidtke, the principal disclosed action is the appointment of new leadership, making this an exec_appointment event. The CEO transition is material to a reasonable investor's assessment of the company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
EX-99.1
The exhibit announces the appointment of Robin Hoksnes Karlsen as an executive director of 707 Cayman Holdings Limited by the board of directors, with entry into a standard director agreement. This is a clear executive appointment disclosure. The appointment is material because it involves a new executive director joining the board with stated expertise in real estate, digital assets, and blockchain technologies that the company explicitly identifies as relevant to its strategic direction in "AI-powered blockchain-enabled supply-chain technologies."
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
The filing discloses under Item 5.02 the appointment of two new directors to the Board effective June 21, 2026: Ruoxin (Skyler) Wang and Zhang Zhixiang. The prose explicitly states "the Board of Directors...appointed Ruoxin (Skyler) Wang and Zhang Zhixiang as members of the Board, and they accepted their appointments as directors." This is a clear executive appointment event, material to investors as board composition affects governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-30
Item 5.02
The filing discloses the election of Paul W. Burkett as a director effective July 1, 2026, with appointment to three Board committees (Audit, Corporate Governance and Nominating, and Transaction Committee). While the section also mentions Michael J. Wartell's resignation, the principal disclosed action centers on the appointment of a new director with significant committee responsibilities. The appointment of an independent director to key governance committees is material to investors' assessment of board composition and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-30
The filing discloses both the retirement of interim CFO Jeffrey Church (effective July 1, 2026) and the appointment of Josh Blacher as the new interim Chief Financial Officer under a master services agreement with Danforth Health, Inc. While both events occur, the principal disclosed action centers on the appointment of Blacher to the CFO role, with detailed biographical information and compensation terms ($475/hour). The departure of Church is secondary context. This is material as CFO changes affect investor assessment of financial reporting and governance.
View raw filing on EDGAR →